IBO Impact BioMedical
- 2.599
- -0.101-3.74%
- 2.500
- -0.099-3.81%
Impact BioMedical News
Express News | Impact Biomedical Inc - Canadian Patent Term Expires in May 2037
Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker Technology Targeting Inflammatory Disease
Express News | Impact Biomedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease
Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation With Strong Support From Partners and Affiliates
12 Health Care Stocks Moving In Friday's Intraday Session
Impact BioMedical Says Mark Suseck to Be Oper Chief and Todd Macko to Be CFO >IBO
Impact BioMedical Names Frank D. Heuszel as CEO >IBO
Press Release: Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth
Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth
DSS Inc. Buys $2,330 Worth of Impact Biomedical Shares
DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value
Sector Update: Health Care Stocks Higher Late Afternoon
Sector Update: Health Care
Impact BioMedical Shares Fall on Market Debut
Express News | Impact Biomedical Inc - Shares to Begin Trading on NYSE American Under Ticker 'ibo'
Express News | Impact Biomedical Inc - Offering Expected to Close on September 17, 2024
Express News | Impact Biomedical Inc. Announces Pricing of Initial Public Offering
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
Express News | Impact Biomedical Inc Says It Adds Dawson James Securities Inc as an Underwriter to IPO - SEC Filing
Impact BioMedical | 10-Q: Q2 2024 Earnings Report
Analysis
Price Target
No Data
No Data
